D
Absci Corporation ABSI
$3.21 $0.103.22%
Recommendation
Sell
Prev Close
$3.21
Volume
5,762
Avg Vol (90D)
1,080,917
Market Cap
$368.69M
Dividend & Yield
--
52-Week Range
$2.02 - $6.72
P/E (TTM)
--
EPS (TTM)
-$0.9358
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Cathie Wood's ARK Investment bought 202.6K shares of Absci today
12/6/2024 - The Fly
AbSci (ABSI) Receives a New Rating from JonesTrading
12/5/2024 - TipRanks Financial Blog
AbSci (ABSI) Receives a New Rating from JonesTrading
12/5/2024 - TipRanks Financial Blog
Cathie Wood's ARK Investment bought 137.9K shares of Absci today
12/5/2024 - TipRanks Financial Blog
Cathie Wood's ARK Investment bought 137.9K shares of Absci today
12/5/2024 - The Fly
Absci a new buy at Jones on AI platform to design antibodies
12/4/2024 - Seeking Alpha - Healthcare
Absci a new buy at Jones on AI platform to design antibodies
12/4/2024 - SeekingAlpha.com: All News
Absci initiated with a Buy at JonesResearch
12/4/2024 - TipRanks Financial Blog
Absci initiated with bullish view at JonesResearch, here's why
12/4/2024 - The Fly
Cathie Wood's ARK Investment bought 400.3K shares of Absci today
12/4/2024 - TipRanks Financial Blog
Cathie Wood's ARK Investment bought 400.3K shares of Absci today
12/4/2024 - The Fly
Absci management to meet virtually with KeyBanc
11/25/2024 - The Fly
Brokerages Set Absci Co. (NASDAQ:ABSI) Target Price at $8.67
11/24/2024 - Ticker Report
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
11/21/2024 - GuruFocus
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
11/21/2024 - Globe Newswire
Absci Co. (NASDAQ:ABSI) Given Consensus Recommendation of "Buy" by Brokerages
11/21/2024 - MarketBeat
Absci Corporation: Struggling To Live Up To Its AI Promise
11/20/2024 - SeekingAlpha
Tech Moves: Former leaders at Qualtrics and AWS land CEO roles; VertueLab adds board member
11/20/2024 - GeekWire
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
11/20/2024 - CNW Group - News Releases
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
11/20/2024 - PR Newswire
Absci Co. (NASDAQ:ABSI) Stock Holdings Increased by Sumitomo Mitsui Trust Group Inc.
11/19/2024 - Ticker Report
Absci management to meet virtually with KeyBanc
11/18/2024 - TipRanks Financial Blog
Absci management to meet virtually with KeyBanc
11/18/2024 - The Fly
HC Wainwright Reiterates Buy Rating for Absci (NASDAQ:ABSI)
11/17/2024 - Ticker Report
Equities Analysts Issue Forecasts for Absci FY2024 Earnings
11/15/2024 - MarketBeat - AP News
Income Statement
Total Revenue (TTM)
$4.21M
EBITDA (TTM)
-$89.71M
EBIT (TTM)
-$103.35M
Net Income (TTM)
-$97.67M
Balance Sheet
Total Assets (Q)
$235.23M
Total Debt (Q)
$11.99M
Total Liabilities (Q)
$33.90M
Book Value Per Share (Q)
$1.76
Cash Flow
Cash from Operations (TTM)
-$70.36M
Cash from Investing (TTM)
-$41.66M
Cash from Financing (TTM)
$80.31M
Net Change in Cash (TTM)
-$31.72M
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Loading...
Beta
3.85
7-Day Total Return
5.25%
30-Day Total Return
-25.17%
60-Day Total Return
-16.62%
90-Day Total Return
-17.90%
Year to Date Total Return
-13.01%
1-Year Total Return
38.96%
2-Year Total Return
16.30%
3-Year Total Return
-68.47%
5-Year Total Return
--
52-week Low
Dec 11, 2023 - $2.02
52-week High
Apr 09, 2024 - $6.72
Valuation
Market Cap
$368.69M - Small Cap
Enterprise Value
$253.61M
Price/Sales (TTM)
86.76
Price/Book (Q)
1.82
Dividends and Shares
Shares Outstanding
113.61M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.absci.com
Phone Number
360 949 1041
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create... more
NASDAQ 12/09/2024 4:00PM Eastern Quotes delayed
Weiss Ratings